1. A "next generation" coronavirus booster jab which may only need administering once a year has been approved for use in adults. The Medicines and Healthcare products Regulatory Agency (in the UK) has authorized Moderna's bivalent vaccine, which targets the original Covid strain and the Omicron variant. Known as mRNA-1273.214, the dose is an updated version of the Moderna vaccine which is already in use for first, second and booster doses, and it will be the first dose approved in the UK which targets two strains of the virus. Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually. (Source: bloomberg.com)
Keep reading with a 7-day free trial
Subscribe to News Items to keep reading this post and get 7 days of free access to the full post archives.